Top Big Cap Negative News Movers Premarket: XENE: -23% Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
Top Big Cap Negative News Movers Premarket: XENE: -23% Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program